Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems

Equine Veterinary Journal

Volumn 33, Issue 7, 2001, Pages 693-698

  McMonagle, E L J ^a   Taylor, S ^a   Van Zuilekom, H ^b   Sanders, L ^b   Scholtes, N ^b   Keanie, L J ^a   Hopkins, C A ^a   Logan, N A ^a   Bain, D ^a   Argyle, D J ^a   Onions, D E ^a   Schijns, V E ^b   Nicolson, L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b lntervet International BV   (Netherlands)

Author keywords

Cytokine; Horse; IL 12; Interferon gamma; Interleukin; Th1 cytokine

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS; INSECTA; MAMMALIA; UNIDENTIFIED BACULOVIRUS;

COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 SUBUNIT P35; INTERLEUKIN 12 SUBUNIT P40; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT;

AMINO ACID SEQUENCE; ANIMAL; ARMYWORM; ARTICLE; BACULOVIRUS; BIOSYNTHESIS; CELL LINE; CELLULAR IMMUNITY; CHEMISTRY; DNA VECTOR; GENE EXPRESSION REGULATION; GENETICS; HORSE; HORSE DISEASE; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; BACULOVIRIDAE; CELL LINE; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENETIC VECTORS; HORSE DISEASES; HORSES; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; MOLECULAR SEQUENCE DATA; PROTEIN SUBUNITS; SPODOPTERA; SUPPORT, NON-U.S. GOV'T;

EID: 0035512995     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516401776249426     Document Type: Article

References (23)

1. Aggarwal, N. and Holmes, M. A. (1999) Characterisation of equine T helper cells: demonstration of Th1- and Th2-like cells in long-term equine T-cell cultures. Res. vet. Sci. 66, 277-279.
2. Anderson, R., Macdonald, I., Corbett, T., Hacking, G., Lowdell, M.W. and Prentice, H.G. (1997) Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus. Hum. Gene Ther: 8, 1125-1135.
3. Boretti, F.S., Leutenegger. C.M., Mislin, C., Hofmann-Lehmann, R., Konig, S., Schroff, M., Junghans, C., Fehr, D., Huettner, S.W., Habel, A., Flynn, J.N., Aubert, A., Pedersen, N.C., Wittig, B. and Lutz, H. (2000) Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS 14, 1749-1757.
4. Flynn, J.N., Hanlon, L. and Jarrett, O. (2000) Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunol. 101, 120-125.
5. Gately, M.K., Renzetti, L.M., Magram, J., Stern, A.S., Adorini, L., Gubler, U. and Presky, D.H. (1998)The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Ann. Rev. Immunol. 16,495-521.
6. Gubler, U., Chua, A.O., Schoenhaut, D.S., Dwyer, C.M., McComas, W., Motyka, R. Nabavi, N., Wolitzky, A.G., Quinn, P.M., Familletti, P.C. and Gately, M.K. (1991) Coexpression of two distinct genes is required to generate secreted, bioactive cytotoxic lymphocyte maturation factor. Proc. natl. Acad. Sci. USA 88, 4143-4147.
7. Hanlon, L., Argyle, D.J., Bain, D., Nicolson, L., Dunham, S., Golder, M.C., McDonald, M., McGillivray, C., Jarrett, O., Neil, J.C. and Onions, D.E. (2001) Feline leukemia virus DNA vaccine efficacy is enhanced by co-administration with interleukin-12(IL-12) and IL-18 expression vectors. J. Virol. 75, 8424-8433.
8. Horohov, D.W. (2000) Equine T-cell cytokines: protection and pathology. Vet. Clin. N. Am.: Equine Pract. 16, 1-14.
9. Kokuho, T., Watanabe, S., Yokomizo, Y. and Inumaru, S. (1999) Production of biologically active, heterodimeric porcine interleukin-12 using a monocistronic baculoviral expression system. Vet. Immunol. Immunopath. 72, 289-302.
10. Kozak, M. (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148.
11. Leutenegger, C.M., Boretti, F.S., Mislin, C.N., Flynn, J.N., Schroff, M., Habel, A., Junghans, C., Koenig-Merediz, S.A., Sigrist, B., Auhert, A., Pedersen, N.C., Wittig, B., Lutz, H.J. (2000). Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12). IL-16. or a CpG motif. J. Virol. 74. 10447-10457.
12. Lieschke, G.J., Rao, P.K., Gately, M.K. and Mulligan, R.C. (1997) Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Natl. Biotechnol. 15, 35-40.
13. Ling, P., Gately, M.K., Gubler, U., Stern, A.S., Lin, P., Hollfelder, K., Su, C., Pan, Y.-C.E. and Hakimi, J. (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154, 116-127.
14. Lode, H.N., Dreier, T., Xiang, R., Varki, N.M., Kang, A.S. and Reisfeld, R.A. (1998) Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc. natl. Acad. Sci. USA. 95, 2475-2480.
15. Nicolson, L., Penha-Goncalves, M.N., Keanie, J.L. Logan, N.A., Argyle, D.J. and Onions, D.E. (1999) Nucleotide sequence of equine interleukin 12 and 18 cDNAs. Immunogenetics. 50, 94-97.
16. Park, A.Y. and Scott, P. (2001) IL-12: keeping cell-mediated immunity alive. Scand. J. Immunol. 53, 529-532.
17. Rodolfo, M. and Colombo, M.P. (1999) Interleukin-12 as an adjuvant for cancer immunotherapy. Methods 19, 114-120.
18. Schijns, V.E.C.J. and Horzinek, M.C. (1997) Cytokines in Veterinary Medicine. CAB International, New York, USA.
19. Scott, P. and Trinchieri, G. (1997) IL-12 as an adjuvant for cell-mediated immunity. Semin. Immunol. 9, 285-291.
20. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13, 251-276.
21. Trinchieri, G. and Scott, P. (1999) Interleukin-12: basic principles and clinical applications. Curr. Top Microbiol. Immunol. 238, 57-78.
22. Zitvogel L., Tahara, H., Cai, Q., Storkus, W.J., Muller, G., Wolf, S.F, Gately, M., Robbins, P.D. and Lotze, M.T. (1994) Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5, 1493-1506.
23. Zuckermann, F.A., Martin, S., Husmann, R.J. and Brandt, J. (1999) Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Adv. vet. Med. 41, 447-461.